NASDAQ:CYCN

Cyclerion Therapeuticsinc Stock News

etoro logo Buy CYCN
*Your capital is at risk
$3.00
-0.0200 (-0.662%)
At Close: Jun 03, 2026

Cyclerion Updates Corporate Progress

11:00am, Friday, 10'th Apr 2020
Cyclerion Therapeutics, Inc. (CYCN), a clinical-stage biopharmaceutical company focused on the development of soluble guanylate cyclase (sGC) stimulators for the treatment of serious and orphan diseas
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

Visa suspension worries New York farm leaders

08:52pm, Friday, 20'th Mar 2020
New York is the second-largest apple producing state in the U.S., and H-2A workers staff many orchards.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Progenics (PGNX) and Cyclerion Therapeutics (CYCN). Progenics (PGNX) In
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Progenics (PGNX – Research Report)
Tennis was hurled into the coronavirus maelstrom on Monday after the overnight cancellation of the Indian Wells Masters
The Brandenburg Social Democratic Party (SPD) in Germany wants to use 10 million euros ($11.29 million) to help spread the “Tesla effect” across the country. Brandenburg SPD parliamentary group ch
Companies offer incentives to try to tempt workers from Philippines and elsewhere amid high demand

78 Biggest Movers From Yesterday

10:16am, Thursday, 20'th Feb 2020
Gainers Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) shares surged 44.6% to close at $5.84 on Wednesday. Myomo, Inc. (NYSE: MYO) shares jumped 43.4% to close at $7.83 on...
Ten new option listings and two option delistings on January 23rd AKRO AQST CYCN ITRN OBSV PHAS PHAT STOK XP MDR TOO

DDD, NVTA among premarket gainers

02:27pm, Monday, 13'th Jan 2020
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors.Verona Pharma PLC (NASDAQ:VRNA) +54% on positive ensifentrine data.Mereo BioP
– Results in 110 subjects demonstrate favorable safety, CNS pharmacokinetics, and evidence of target engagement – – Study underway in elderly subjects to further assess.
Activity in the biotech space is likely to pick up this week. Events are likely to be headlined by the annual JPMorgan Healthcare Conference. Biotech stocks closed 2019 with gains, although they under
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
– Management to review the Company's sGC clinical pipeline programs: praliciguat for diabetic nephropathy, olinciguat for sickle cell disease, and IW-6463 for neurodegenerative.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE